AXSM
Axsome Therapeutics Inc.
Company Overview
| Mkt Cap | $5.79B | Price | $135.75 |
| Volume | 1.24M | Change | +0.56% |
| P/E Ratio | -20.1 | Open | $123.90 |
| Revenue | $385.7M | Prev Close | $134.99 |
| Net Income | $-287.2M | 52W Range | $75.56 - $139.13 |
| Div Yield | N/A | Target | $177.11 |
| Overall | 60 | Value | 40 |
| Quality | 60 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyAxsome Therapeutics Inc. (AXSM) is a leading diversified company in the Biotechnology industry, currently trading at $135.75 with a market capitalization of $5.79 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating solid quality metrics with a MarketXLS quality score of 60.
Today's trading session shows AXSM with a volume of 1.24 million shares. The stock opened down 8.22% from yesterday's close of $134.99. Current analyst estimates project earnings of $-3.49 per share for this year, with next year targeting $0.58.
AXSM demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for AXSM include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 30.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 03:45 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXSM | $135.75 | +0.6% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Axsome Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW